Shaalan Beg MD MBA FASCO

Reimagining cancer clinical trials.
Foodie, family guy, digital health.
FCOI:

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Great perspective from @PauloBergerot in @ASCO Daily News on a critical challenge in #ExerciseOncology: moving beyond the optimal exercise dose to interventions that are feasible, accessible, and sustainable in patients’ everyday lives #ASCOQLTY26

https://t.co/qPbCLDvb75

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

@AshleySumrallMD @SamfordU 👏🏻👏🏻

[Kimmie Ng, MD, MPH @KimmieNgMD]

Our atlas of young-onset CRC is finally out in @NatureMedicine! We found a unique biology in younger patients that may explain the aggressive nature of this disease. This was a monumental effort with colleagues at @MassGenBrigham and @broadinstitute. @DFarberYoungCRC

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

@DrRoyHerbst @theNAMedicine Congratulations!

[ASCO @ASCO]

ASCO Members! You now get full access to ASCO Meetings content 30 days post-meeting. Explore the latest science faster! View content from the 2026 ASCO Annual Meeting: https://t.co/vXOON8nkQn

Coming soon: An AI-powered agent from ASCO & Google Cloud to simplify your research.

[Hao Zhu Lab @Zhu_Lab]

We are looking to hire post-doctoral fellows to work on somatic mosaicism, regeneration, and cancer development, please reach out to me if you are interested! @CRI_UTSW

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

@andyzwang @TimothyJBrownMD Imagine how much easier it'll be to get from the cancer center to the rad onc building.

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

Hey, @TimothyJBrownMD, can an F-150 do this?

[Reuters @Reuters]

Tesla unveiled a redesigned Roadster equipped with thrusters that enable it to fly short distances, nearly nine years after it first showed a next-generation version of its electric sports car, and said it would start production in 2028 https://t.co/xYuT9Izmvf

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

@skopetz @MDAndersonnews @adasarimd Congratulations!!

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

Dr. @QasimHussainiMD giving an amazing discussion of two studies on #ExerciseOncology presented at @ASCO Quality Care Symposium this morning.

https://t.co/CVwhdtrTau

#ASCOQLTY26 @crisbergerot @PauloBergerot

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

@TimothyJBrownMD 🤷🏻‍♂️

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

Fantastic oral abstract discussion by Dr. @CharlesJiangMD at @ASCO Quality Care Symposium today!

https://t.co/FfvEgD5hPl

#ASCOQLTY26 @utswcancer @UTSWMedCenter

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

Great to see work from @ASCO Quality Care Symposium simultaneously published in @JCO_ASCO today:

“Effectiveness of a Multisite Oncology Financial Navigation Intervention: The Lessening the Impact of Financial Toxicity Clinical Trial.”

https://t.co/QZz4YpzWt1

#ASCOQLTY26

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

Geographical access to clinical trials remains the number one barrier to enrollment.

Look forward to hearing how technology-enabled services are being used by sites to improve access to cancer trials. #ascoqlty26

[Ryan Nipp, MD, MPH, MBA, FASCO @RyanNipp]

Growing excitement for the @ASCO Quality Care Symposium (#ASCOQLTY26) this week!

Nice overview of one of the studies on Decentralizing Clinical Trials being presented at the meeting:

https://t.co/1yhjaO5Mzj

@JamesFanWu @crisbergerot @ShaalanBeg
#CancerResearch #ClinicalTrials

[Shaalan Beg MD MBA FASCO @ShaalanBeg]

@TsengJennifer @SyedAAhmad5 Congratulations @SyedAAhmad5.

You're an amazing mentor, colleague and program builder.

Wayne State is very fortunate to have you.

[Oncology Brothers @OncBrothers]

Atezolizumab is now @FDA ✅ off #ATOMIC Ph III, adj mFOLFOX + Atezo vs. mFOLFOX in Stg III dMMR colon ca.

- 3yr DFS 86.4% vs 76.6% (HR 0.50)
- OS not mature
- ⬆️ Gr4 neutropenia with Atezo.
- How much is chemo benefitting? Role of NICHE2?
- @ASCO Plenary!

#gism #OncTwitter

[ASCO @ASCO]

How has teamwork transformed patient outcomes in your practice? Bring Dr. Elizabeth Mittendorf’s @ASCOPres theme—Intentional Teams. Exceptional Care.—to life on the #ASCO27 stage during the ASCO Voices session.

🎙️ Submit your audition by November 13: https://t.co/VEQT4R5Ho3

[Oncology Brothers @OncBrothers]

Based off HER2CLIMB-05, Tucatinib is now @FDA ✅ as maintenance for HER2+ mBC, PhIII, THP —> HP +/-Tucatinib

- Improved PFS in all subsets
- mPFS: 24.9mos vs. 16.3mos (HR: 0.64)
- ⬆️ AEs with Tucatinib (LFTs & diarrhea)

#BreastCancer #bcsm #OncTwitter

[Oncology Brothers @OncBrothers]

We have 3 Anti-Her2 options today for Upper GI adenocarcinoma. Here is the table outlining dose, common toxicities, and clinical pearls in managing these AEs that we touched on during our #ToxCheck discussion with @ShrutiPatelMD & @Sam_Cytryn

#MedTwitter #MedX #OncTwitter

[Todd Aguilera MD PhD @aguilera_md]

Getting ready to present the phase II GRECO-2 trial Tuesday at #ASTRO26. Can’t stop thinking of you, @TaniguchiMD. There is no way I can represent the purple hair like you did, but I’ll do my best to represent the SOD story.

Missing you, brother. RIP.